par De Marneffe, Michel 
;Waterschoot, Patrick ;Bernard, Alain ;Dubois, Philippe;Boujelben, F.;Liebens, Isabelle ;Englert, Marc
Référence Cardiovascular drugs and therapy, 4, 2, page (523-527)
Publication Publié, 1990-03
;Waterschoot, Patrick ;Bernard, Alain ;Dubois, Philippe;Boujelben, F.;Liebens, Isabelle ;Englert, Marc Référence Cardiovascular drugs and therapy, 4, 2, page (523-527)
Publication Publié, 1990-03
Article révisé par les pairs
| Résumé : | The electrophysiologic effects of xamoterol were studied in ten patients with electrophysiologic evidence of sinus node dysfunction. A significant shortening of mean sinus cycle length, maximal corrected sinus-node recovery time, and the mean of the three longest corrected sinus-node recovery times was observed after intravenous administration of 0.1 mg/kg of xamoterol. The atrioventricular (AV) conduction time and the effective and functional refractory periods of the AV node were shortened as the effective refractory period of the atrium. These effects suggest that xamoterol could be tried safely for the treatment of patients with moderate symptoms due to sinus-node disease. © 1990 Kluwer Academic Publishers. |
